These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 22977662)
1. Expression of phosphorylated mTOR and its regulatory protein is related to biological behaviors of ameloblastoma. Li N; Zhong M; Song M Int J Clin Exp Pathol; 2012; 5(7):660-7. PubMed ID: 22977662 [TBL] [Abstract][Full Text] [Related]
2. The mTOR downstream regulator (p-4EBP1) is a novel independent prognostic marker in ovarian cancer. Alabdullah ML; Ahmad DA; Moseley P; Madhusudan S; Chan S; Rakha E J Obstet Gynaecol; 2019 May; 39(4):522-528. PubMed ID: 30712414 [TBL] [Abstract][Full Text] [Related]
3. Activation of Akt/mTOR pathway is associated with poor prognosis of nasopharyngeal carcinoma. Wang W; Wen Q; Xu L; Xie G; Li J; Luo J; Chu S; Shi L; Huang D; Li J; Fan S PLoS One; 2014; 9(8):e106098. PubMed ID: 25165983 [TBL] [Abstract][Full Text] [Related]
4. Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas. Korkolopoulou P; Levidou G; El-Habr EA; Piperi C; Adamopoulos C; Samaras V; Boviatsis E; Thymara I; Trigka EA; Sakellariou S; Kavantzas N; Patsouris E; Saetta AA Histopathology; 2012 Aug; 61(2):293-305. PubMed ID: 22690797 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of the mTOR pathway in intrahepatic cholangiocarcinoma. Wang Z; Zheng T; Wu Q; Wang J; Wu C; Wang J Neoplasma; 2012; 59(2):137-41. PubMed ID: 22248270 [TBL] [Abstract][Full Text] [Related]
6. A comprehensive immunohistochemical approach of AKT/mTOR pathway and p-STAT3 in mycosis fungoides. Levidou G; Siakantaris M; Papadaki T; Papadavid E; Vassilakopoulos TP; Angelopoulou MK; Marinos L; Nikolaou V; Economidi A; Antoniou C; Patsouris E; Korkolopoulou P J Am Acad Dermatol; 2013 Sep; 69(3):375-84. PubMed ID: 23685026 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous activation of impaired autophagy and the mammalian target of rapamycin pathway in oral squamous cell carcinoma. Yin X; Hu L; Feng X; Wang H; Zhang C; Wang H; Wang S J Oral Pathol Med; 2019 Sep; 48(8):705-711. PubMed ID: 31132188 [TBL] [Abstract][Full Text] [Related]
8. [Study on activation of AKT/mTOR pathway in anaplastic large cell lymphoma]. Li JF; Li GD; Gu L; Liu WP; Li FY; Liao DY; Ma ZG Zhonghua Xue Ye Xue Za Zhi; 2008 Oct; 29(10):649-53. PubMed ID: 19176054 [TBL] [Abstract][Full Text] [Related]
9. PI3K/AKT/mTOR pathway activation in primary and corresponding metastatic breast tumors after adjuvant endocrine therapy. Beelen K; Hoefnagel LD; Opdam M; Wesseling J; Sanders J; Vincent AD; van Diest PJ; Linn SC Int J Cancer; 2014 Sep; 135(5):1257-63. PubMed ID: 24501006 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical and molecular analysis of PI3K/AKT/mTOR pathway in esophageal carcinoma. Tasioudi KE; Sakellariou S; Levidou G; Theodorou D; Michalopoulos NV; Patsouris E; Korkolopoulou P; Saetta AA APMIS; 2015 Aug; 123(8):639-47. PubMed ID: 25912437 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of the mammalian target of rapamycin signalling pathway in extramammary Paget's disease. Chen S; Nakahara T; Uchi H; Takeuchi S; Takahara M; Kido M; Dugu L; Tu Y; Moroi Y; Furue M Br J Dermatol; 2009 Aug; 161(2):357-63. PubMed ID: 19438435 [TBL] [Abstract][Full Text] [Related]
12. Activation of mTOR signaling pathway associated with adverse prognostic factors of epithelial ovarian cancer. No JH; Jeon YT; Park IA; Kim YB; Kim JW; Park NH; Kang SB; Han JY; Lim JM; Song YS Gynecol Oncol; 2011 Apr; 121(1):8-12. PubMed ID: 21276607 [TBL] [Abstract][Full Text] [Related]
13. mTOR/P70S6K promotes spermatogonia proliferation and spermatogenesis in Sprague Dawley rats. Xu H; Shen L; Chen X; Ding Y; He J; Zhu J; Wang Y; Liu X Reprod Biomed Online; 2016 Feb; 32(2):207-17. PubMed ID: 26706460 [TBL] [Abstract][Full Text] [Related]
14. 4′,6-dihydroxy-4-methoxyisoaurone inhibits the HIF-1α pathway through inhibition of Akt/mTOR/p70S6K/4E-BP1 phosphorylation. Mi C; Ma J; Shi H; Li J; Wang F; Lee JJ; Jin X J Pharmacol Sci; 2014; 125(2):193-201. PubMed ID: 25075425 [TBL] [Abstract][Full Text] [Related]
15. mTOR activity in AIDS-related diffuse large B-cell lymphoma. Browne SH; Diaz-Perez JA; Preziosi M; King CC; Jones GA; Jain S; Sun X; Reid EG; VandenBerg S; Wang HY PLoS One; 2017; 12(2):e0170771. PubMed ID: 28192480 [TBL] [Abstract][Full Text] [Related]
16. [Expression of PI3K pathway proteins in refractory epilepsy associated with cortical malformation development]. Ni HC; Sun FH; Piao YS; Ma XL; Lu DH Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):391-5. PubMed ID: 22932407 [TBL] [Abstract][Full Text] [Related]
17. The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif. Nojima H; Tokunaga C; Eguchi S; Oshiro N; Hidayat S; Yoshino K; Hara K; Tanaka N; Avruch J; Yonezawa K J Biol Chem; 2003 May; 278(18):15461-4. PubMed ID: 12604610 [TBL] [Abstract][Full Text] [Related]
18. Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells. Bishop JD; Nien WL; Dauphinee SM; Too CK J Endocrinol; 2006 Aug; 190(2):307-12. PubMed ID: 16899564 [TBL] [Abstract][Full Text] [Related]
19. Phosphorylated p70S6K expression is an independent prognosticator for patients with esophageal squamous cell carcinoma. Li SH; Chen CH; Lu HI; Huang WT; Tien WY; Lan YC; Lee CC; Chen YH; Huang HY; Chang AY; Lin WC Surgery; 2015 Mar; 157(3):570-80. PubMed ID: 25726316 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of GOLPH3 associated with the progression of gastric cancer: a preliminary study. Peng J; Fang Y; Tao Y; Li K; Su T; Nong Y; Xie F; Lai M PLoS One; 2014; 9(10):e107362. PubMed ID: 25286393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]